FDA
-
-
-
-
-
-
-
Acerus Announces Significant Improvement in NATESTO® Insurance Coverage in the United States
-
-
-
-
-
-
-
NATESTO® Spermatogenesis Study Final Results Accepted for Presentation at the American Society for Reproductive Medicine 75th Annual Scientific Conference
-
-
-
-
-
-
-
Acerus Announces Expansion of NATESTO® Agreement with medac and the Submission of NATESTO® Dossier in Europe
-
-
-
-
-
-
-
Acerus Announces Buyout of All Obligations under the Mattern License Agreement
-
-
-
-
-
-
-
Acerus Announces Launch of URIVARX® in Canada
-
-
-
-
-
-
-
Acerus Announces NATESTO® License Agreement with Therios Healthcare
-
-
-
-
324,774 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

